Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
RYTM
RYTM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RYTM News
Rhythm Pharmaceuticals Reports Positive Phase 3 Trial Data for Setmelanotide
Mar 02 2026
Benzinga
Rhythm Pharmaceuticals Reports Positive Phase 3 Results for Obesity Treatment
Mar 02 2026
NASDAQ.COM
Rhythm Pharmaceuticals Reports Positive Data on Weight Loss Therapy Setmelanotide
Mar 01 2026
Newsfilter
RYTM Stock 52-Week Highs and Lows Analysis
Feb 27 2026
NASDAQ.COM
Rhythm Pharmaceuticals Reports Strong Q4 Results Exceeding Expectations
Feb 27 2026
Benzinga
Rhythm Pharmaceuticals Q4 2025 Earnings Call Highlights
Feb 26 2026
seekingalpha
Rhythm Pharma (RYTM) Earnings Call Transcript
Feb 26 2026
NASDAQ.COM
Rhythm Pharmaceuticals Set to Announce Q4 Earnings
Feb 25 2026
seekingalpha
Overview of FDA Regulatory Developments
Feb 25 2026
NASDAQ.COM
Perceptive Advisors Acquires 431,432 Shares of Praxis Precision Medicines
Feb 22 2026
Yahoo Finance
Perceptive Advisors Increases Stake in Celcuity
Feb 22 2026
Yahoo Finance
RBC Initiates Coverage on Rhythm Pharmaceuticals with Outperform Rating
Feb 19 2026
Benzinga
Latest Rating Changes on Wall Street
Feb 19 2026
CNBC
Three Stocks Set to Outperform the Market in 2026
Feb 16 2026
Fool
Rhythm Pharmaceuticals Stock Soars with Significant Growth Potential
Feb 02 2026
NASDAQ.COM
Rhythm Pharmaceuticals: A Hidden Growth Stock Soaring
Feb 02 2026
Fool
Show More News
